← All companies

VERU

Veru Inc.

VERU Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.26

+0.04 +1.80%

Key statistics

from XBRL data in SEC filings

Market cap

$36.3M

Revenue (TTM)

$10.6M

Net income (TTM)

-$14.0M

EPS (TTM)

$-0.78

P/E ratio

—

Dividend yield

3.10%

Free cash flow

-$30.0M

Cash

$27.6M

Total assets

$43.1M

Gross margin

55.2%

52-week range

$2.05 – $7.33

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement Jul 2, 2026 8-K Other events Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Director or officer change; Shareholder vote results Mar 13, 2026 10-Q Quarter ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release) Feb 11, 2026 10-K Fiscal year ended 2025-09-30 Dec 17, 2025 8-K Results of operations (earnings release) Dec 17, 2025 8-K Entered a material agreement; Other events Oct 30, 2025 8-K Terminated a material agreement Sep 26, 2025 8-K Other events Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jul 25, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change; Shareholder vote results Mar 14, 2025 8-K Delisting notice or listing-rule failure Feb 28, 2025 10-Q Quarter ended 2024-12-31 Feb 13, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Triggering event accelerating an obligation; Other events Jan 3, 2025 10-K Fiscal year ended 2024-09-30 Dec 16, 2024 8-K Entered a material agreement Sep 20, 2024 8-K Delisting notice or listing-rule failure Aug 30, 2024 8-K Terminated a material agreement Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change Aug 2, 2024 8-K Shareholder vote results Jul 2, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Changed accountants May 22, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement Apr 26, 2024 8-K Other events Apr 25, 2024 10-Q Quarter ended 2023-12-31 Apr 1, 2024 10-K/A Fiscal year ended 2023-09-30 Apr 1, 2024 8-K Delisting notice or listing-rule failure Feb 28, 2024